AMRN Q1 2021 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$142M-8.3% YoY

Gross Profit

$114M80.1% margin

Operating Income

-$1M-0.9% margin

Net Income

-$2M-1.1% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-15.0%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$990M

Total Liabilities

$356M

Stockholders' Equity

$635M

Cash & Equivalents

$291M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$142M	$155M	-8.3%
Gross Profit	$114M	$120M	-5.3%
Operating Income	-$1M	-$24M	+94.5%
Net Income	-$2M	-$21M	+92.1%

Revenue Segments

Product

$141M99%

Licensing And Royalty

$787,0001%